Resources for Antibody Therapeutics Purification

Discover resins—developed to bind antibody subdomain regions—that can support the downstream process for a variety of antibody formats.

Gain insight into using HIC purification, including viral clearance data, for monoclonal antibodies requiring aggressive strategies for aggregate clearance.

Learn how POROS HIC resins provide excellent resolution, capacity, and product recovery for a wide range of biomolecules.

Gain knowledge from this case study describing mAb aggregate removal using HIC in flow-through mode, resulting in improved process efficiency and productivity, compared to a mixed-mode bind-elute step.

Overcome the purification challenges presented by complex novel formats derived from conventional  antibody structures, including Fab fragments, Fc-fusion proteins, and bispecifics.

Discover how a customer was able to rapidly implement antibody affinity resins into their commercial manufacturing process for a next-generation antibody therapeutic. 

Discover solutions for common purification, analysis, and quality evaluation challenges when manufacturing modern antibody-derived therapies. 

Explore innovative solutions that surmount technical hurdles and enhance downstream processes, producing high product yield at lower costs.  {Image needs to be provided}

Learn about innovative purification tools to help maximize productivity of downstream processing of traditional and complex antibodies therapeutics.

Review application data of our new Protein A resin designed to help improve the productivity and efficiency of your antibody purification process.

Explore application data of our subdomain-specific affinity portfolio developed to address purification challenges with novel antibody molecules.

See how antibody subdomain-specific affinity chromatography can improve the productivity of antibody therapeutics purification workflows.